Trial Profile
Fulvestrant in healthy, postmenopausal women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 01 Dec 2015 New trial record